Janney Montgomery Scott LLC purchased a new stake in shares of Rani Therapeutics Holdings, Inc. (NASDAQ:RANI – Free Report) during the fourth quarter, according to the company in its most recent ...

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI – Get Free Report) has been given an average recommendation of “Buy” by the six ratings firms that are currently covering the stock, Ratings reports. Five ...

These five health care stocks, all belonging to small- or micro-cap categories, notched the highest jump in Stocktwits ...

U.S. stock futures rose on Thursday following Wednesday's advances as investors digest tariff pauses amid earnings reports.

Coherent reported quarterly earnings of 95 cents per share which beat the analyst consensus estimate of 69 cents per share. The company reported quarterly sales of $1.44 billion which beat the analyst ...

SAN JOSE, Calif. - Rani Therapeutics Holdings , Inc. (NASDAQ:RANI), a clinical-stage biotherapeutics company with a market capitalization of $48.3 million, today announced promising results from a ...

Oral semaglutide administered via the RaniPill® HC (RT-116) demonstrated comparable bioavailability, pharmacokinetics and ...

Rani Therapeutics (RANI) announced new pharmacokinetic and pharmacodynamic data from a preclinical study evaluating the oral delivery of the ...

Major employers and innovators recognised at ceremony showcasing Ireland’s pharmaceutical leadership, as sector marks record ...